Related Experiment Video

Updated: Oct 7, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Treatment of status migrainosus

D A Marcus1

  • 1Anesthesiology & Neurology Department, Multidisciplinary Headache Cliniic, Pittsburgh, PA, USA. dawnpainmd@yahoo.com

Expert Opinion on Pharmacotherapy
|May 5, 2001
PubMed

Insights

Status migrainosus, defined as migraine lasting over 3 days, traditionally required hospitalization. Newer migraine-specific medications like dihydroergotamine and triptans have improved treatment outcomes, reducing the need for hospital stays.

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Status migrainosus is defined as migraine episodes persisting for at least 3 days despite treatment.
  • Historically, prolonged migraine attacks necessitated inpatient hospitalizations for intravenous medication administration.
  • The total disability from status migrainosus includes both the migraine duration and hospitalization period.

Purpose of the Study:

  • To review the impact of newer migraine-specific medications on the management of status migrainosus.
  • To assess the reduction in prolonged headache episodes and hospitalizations due to targeted therapies.

Main Methods:

  • Review of traditional treatment approaches for status migrainosus.
  • Analysis of the efficacy of dihydroergotamine and triptans in managing persistent migraine.
  • Evaluation of the impact of these medications on hospitalization rates and treatment response.

Main Results:

  • Development of targeted migraine therapies, including dihydroergotamine and triptans, has been significant.
  • These medications have demonstrated efficacy in treating migraine episodes that previously persisted.
  • A reduction in the number of headache episodes requiring extended treatment or hospitalization has been observed.

Conclusions:

  • Migraine-specific medications have improved the management of status migrainosus.
  • Targeted therapies have reduced the duration of disability and the need for inpatient treatment.
  • Advancements in pharmacotherapy offer better outcomes for patients experiencing prolonged migraine attacks.

More Related Videos

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies05:49

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies

Published on: November 1, 2024

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache05:40

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache

Published on: July 29, 2021

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...